Monitoring with mean kinetic temperature in GxP environments
Supplied by Vaisala Oyj on Tuesday, 14 February, 2017
Regulatory bodies in drug manufacturing and distribution have long been working together to create standards for temperature monitoring that will ensure the quality of drugs, devices and biotechnology. The mean kinetic temperature (MKT) value has been identified as a potential tool for evaluating the impact of temperature on product quality.
Download this paper to discover how to perform the calculation and some basic recommendations for its appropriate use.
Related White Papers
[eBook] Therapeutic proteins: bioprocessing methods for mAb generation
How to optimise your bioprocess for monoclonal...
The solution for a seamless quantitative bioanalysis
High selectivity is a critical element of successful quantitative bioanalysis. Recent...
How to re-socialise your workplace post COVID-19
Learn how to reimagine your workspace, take full advantage of workplace socialisation and...
